Adaptogen Regulation and Conservation: Wild Harvest of Ginseng, Rhodiola and Others

Short answer. There is no single rulebook for adaptogens. The word itself has no standing as a regulatory category in the EU sources we read, and the same plant can be sold under different rules in different places. Separately, reviews describe real pressure on wild populations of American ginseng, rhodiola and eleuthero. Regulation is not a safety guarantee: ask a pharmacist or clinician before combining any herb with a medicine, and see how medicine interactions work.

How the sources define the terms

"Regulation" here means what a named body has said about how these products may be sold or described. "Conservation" means the state of the wild plants they come from. Each statement below is attributed to its body, country and year. Where we did not read a source, we say "not described in the sources we read".

The European Union

• The word "adaptogen." In a 2008 reflection paper, the EMA's herbal committee (HMPC) said the term is not accepted in the pharmacological and clinical terminology commonly used in the EU, and is not appropriate for a marketing authorisation. [1]
• Traditional use registration. The EMA describes three pathways for herbal medicinal products. One, traditional use registration, requires no clinical trials on safety and efficacy as long as sufficient safety data and plausible efficacy are demonstrated. [2]
• Monographs. The committee publishes EU monographs on uses and safe conditions. [2] The rhodiola monograph (Rhodiola rosea L., rhizome and root; March 2024) gives a traditional indication of relief of symptoms of stress, such as fatigue and exhaustion, based exclusively on long-standing use; it advises seeing a doctor if symptoms last longer than 2 weeks, says use under 18 is not recommended, and says use in pregnancy and lactation is not recommended because safety has not been established. [3] The Panax ginseng monograph (May 2024) lists a traditional indication for symptoms of asthenia such as fatigue and weakness, with duration of use up to 3 months. [4] The Eleutherococcus senticosus root monograph (March 2014) says not to be taken for more than 2 months. [5]

The United States

• Dietary supplements. The FDA says that under the Dietary Supplement Health and Education Act of 1994 (DSHEA), it does not have the authority to approve dietary supplements before they are marketed, and that it is generally limited to postmarket enforcement. [6] NCCIH says the same in plain terms: unlike drugs, supplements are not approved by the FDA before they are sold. [7]
• Claims. A supplement can carry a structure/function claim if the firm has substantiation that it is truthful and not misleading, and the label needs a disclaimer. [6] A product represented as treating, preventing or curing a specific disease meets the definition of a drug and is regulated as one. [6] The FDA also says it generally does not approve supplement claims or other labeling before use, so wording on a label is not an approval. [6]
• Where to read more. How supplements are regulated and supplement regulation by country.

Other countries

How Canada, the UK, Australia, India, China and others regulate adaptogen products is not described in the sources we read for this page. For ashwagandha restrictions by country, see is ashwagandha safe and is it banned?.

Conservation: what reviews say

The 2021 rhodiola review argues sourcing should shift toward farms using conservation-minded methods, and that sustainable wild collection standards are needed. [9] Whether any single product meets such standards is not something a label alone shows. The current official conservation status of each species is not described in the sources we read, so we do not state it.

Fair benefit-sharing

Many of these plants come from regions where communities have long used them. The Nagoya Protocol, an agreement under the Convention on Biological Diversity, aims at fair and equitable sharing of benefits from the use of genetic resources, and it addresses traditional knowledge linked to those resources. [12] Proper evidence not found on how well adaptogen supply chains follow it: we read the Convention's overview, and our reading of reviews and monographs found no adaptogen-specific assessment.

Safety: quality and substitution

Substitution of other species is documented for rhodiola by the 2021 review. [9] See contamination, substitution and adulteration and quality testing and certifications. We do not give foraging or plant-identification advice. If someone may have swallowed the wrong plant, call Poison Help in the US at 1-800-222-1222, and ask local botanical experts about wild plants. See at-risk medicinal plants and conservation.